[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Liao et al., 2005 - Google Patents

Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol—implications in freeze-drying

Liao et al., 2005

Document ID
3216644150821997986
Author
Liao X
Krishnamurthy R
Suryanarayanan R
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

Purpose The aim of this study was to investigate the effect of the concentration of the active pharmaceutical ingredient on the physical state of mannitol in frozen aqueous systems. Methods A human monoclonal antibody was used as the model protein. Mannitol and …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/16—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Quaternary ammonium compounds, e.g. amides, ureas
    • A61K47/183—Amino acids or aminosulphonic acids, e.g. glycine, EDTA, aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycol [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/26—Carbohydrates, e.g. mono-, di-, oligosaccharides, nucleic acids, sugar alcohols, amino sugars; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters, glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Similar Documents

Publication Publication Date Title
Liao et al. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol—implications in freeze-drying
Izutsu Applications of freezing and freeze-drying in pharmaceutical formulations
Thakral et al. Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations
Mattern et al. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems
Hawe et al. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol–sucrose–NaCl formulations
Thorat et al. Characterization of phosphate buffered saline (PBS) in frozen state and after freeze-drying
Kim et al. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute
Schwegman et al. Practical formulation and process development of freeze-dried products
Piedmonte et al. Sorbitol crystallization can lead to protein aggregation in frozen protein formulations
Kadoya et al. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols
Fang et al. Effect of controlled ice nucleation on stability of lactate dehydrogenase during freeze-drying
Adams et al. The principles of freeze-drying
DK2193809T3 (en) The albumin-free Factor VIII formulation
KR101567901B1 (en) Lyophilization methods, compositions, and kits
US20070196364A1 (en) Pharmaceutical Formulation and Process
Jena et al. Mutual influence of mannitol and trehalose on crystallization behavior in frozen solutions
Omar et al. Glass transition and crystallization behaviour of freeze-dried lactose–salt mixtures
Jena et al. Effects of excipient interactions on the state of the freeze-concentrate and protein stability
Lim et al. Process cycle development of freeze drying for therapeutic proteins with stability evaluation
JP2007526329A (en) Freeze-drying method to improve excipient crystallization
Hatley et al. Stabilisation and delivery of labile materials by amorphous carbohydrates and their derivatives
Hawe et al. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations
Hackl et al. Effect of arginine on the aggregation of protein in freeze-dried formulations containing sugars and polyol: 1—formulation development
Hackl et al. Effect of arginine on the aggregation of protein in freeze-dried formulations containing sugars and polyol: II. BSA reconstitution and aggregation
Pyne et al. Enthalpic relaxation in frozen aqueous trehalose solutions